Novo Nordisk NVO announced Monday that its oral GLP-1 called Rybelsus wasn’t better than a placebo at delaying the progression of Alzheimer’s disease. It shared few details beyond saying the ...

On its own, LATE dementia is less severe than Alzheimer’s, but in combination, it makes Alzheimer’s symptoms worse, ...

We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

The biomarker improvements in the EVOKE studies are worth noting, observed Howard Fillit, MD, of the Alzheimer's Drug ...

Type 1 diabetes was linked to increased risk for dementia, especially vascular dementia, non-Alzheimer-nonvascular dementia, and Alzheimer disease.

Combining genetic risk with cardiovascular disease risk factors — such as high LDL cholesterol, obesity, and hypertension — ...

New data raise the question of whether statins increase cardiovascular or cerebrovascular hospitalizations in dementia, but ...

During certain times of the day, some people with dementia may become more confused and disoriented. Referred to by ...

A 15-year study sheds light on which eating patterns could help protect you from chronic diseases — or do the opposite.

Using a new form of blood test, researchers can detect biological markers of cognitive decline more than 10 years before a ...

An article about a group of people living with dementia who had just recorded a punk/new wave album inspired a documeantry ...